8-K: Oscar Health Reports Record Profitability, Raises 2026 Outlook

Oscar Health announced record financial results for the first half of 2026, driven by strong operational performance and disciplined pricing, leading to a raised full-year outlook.

Summary

• Oscar Health reported record profitability for the first half of 2026 and raised its full-year 2026 guidance.
• Total revenue for the second quarter of 2026 was $4.9 billion, a significant increase from $2.9 billion in Q2 2025.
• The medical loss ratio (MLR) improved to 79.2% in Q2 2026 from 91.1% in Q2 2025, attributed to disciplined pricing and favorable prior period development.
• The SG&A expense ratio decreased to 14.2% in Q2 2026 from 18.7% in Q2 2025 due to expense management and leverage.
• Earnings from operations were $388.6 million in Q2 2026, a substantial turnaround from a loss of $230.5 million in Q2 2025.
• Net income attributable to Oscar Health was $361.8 million ($1.10 per diluted share) in Q2 2026, compared to a net loss of $228.4 million ($(0.89) per diluted share) in Q2 2025.
• Adjusted EBITDA reached $415.3 million in Q2 2026, a significant improvement from a loss of $199.4 million in Q2 2025.
• Effectuated membership in Individual and Small Group plans grew to 2,963,002 as of June 30, 2026, up from 2,017,058 as of June 30, 2025.

Sentiment

Score: 9

Explanation: StockSavvy.ai views this as a strongly positive report, with significant improvements in profitability and a raised full-year outlook, indicating robust operational performance and strategic execution.

Positives

• Record profitability in the first half of 2026.
• Raised full-year 2026 guidance.
• Significant year-over-year revenue growth in Q2 2026 ($4.9 billion vs. $2.9 billion).
• Substantial improvement in Medical Loss Ratio (MLR) to 79.2% in Q2 2026 from 91.1% in Q2 2025.
• Reduced Selling, General, and Administrative (SG&A) expense ratio to 14.2% in Q2 2026 from 18.7% in Q2 2025.
• Turnaround in earnings from operations, from a loss of $230.5 million in Q2 2025 to a profit of $388.6 million in Q2 2026.
• Strong net income of $361.8 million in Q2 2026, a significant improvement from a net loss in the prior year.
• Membership growth in Individual and Small Group plans to nearly 3 million members.

Negatives

• The company previously had a net loss attributable to Oscar Health, Inc. of $228.4 million in Q2 2025.
• The company previously had a loss from operations of $230.5 million in Q2 2025.
• The company previously had an Adjusted EBITDA loss of $199.4 million in Q2 2025.
• The prior year's MLR was significantly higher at 91.1% in Q2 2025.

Risks

• Potential for unanticipated results of, or changes to, risk adjustment programs or estimates.
• Evolving federal or state laws or regulations, including changes to the ACA, expiration of enhanced Advanced Premium Tax Credits, or new program integrity rules.
• Ability to accurately estimate incurred medical expenses or overall market morbidity.
• Heightened competition in the markets in which the company participates.
• Incurrence of data security breaches of its or its partners' information and technology systems.
• Unfavorable outcomes of lawsuits, audits, investigations, and other third-party claims.
• Adverse market conditions impacting the investment portfolio.
• Uncertainties associated with the utilization of artificial intelligence (AI) and machine learning models.

Future Outlook

The company has raised its full-year 2026 guidance, projecting total revenue between $18.7 billion and $19.0 billion, a Medical Loss Ratio between 81.5% and 82.5%, an SG&A Expense Ratio between 15.6% and 16.1%, and Earnings from Operations between $500 million and $700 million.

Management Comments

• Oscar delivered record profitability in the first half of the year and we are raising our full-year 2026 guidance.
• Our superior operating performance and execution against the fundamentals of our strategy are accelerating the individual market.
• More people are moving between fulland part-time jobs, gig work, and retirement a shift AI will accelerate.
• A durable individual market gives them greater choice and will power the future of American healthcare.
• Oscars consumer products, disciplined pricing, and scalable technology platform will capture this opportunity and position us for long-term profitable growth.

Industry Context

StockSavvy.ai notes that Oscar Health's strong performance and raised outlook in the individual health insurance market align with broader trends of increasing demand for flexible healthcare options, particularly among those in non-traditional employment. The company's focus on technology and member experience appears to be a key differentiator in capturing this evolving market segment.

Stakeholder Impact

• Shareholders: Potential for increased value due to record profitability, improved financial metrics, and raised future outlook.
• Members: Benefit from a company focused on member experience, potentially leading to better access to quality and affordable care.
• Providers: Continued partnership with a growing and financially stable insurer.
• Employees: Positive outlook for the company's growth and stability.

Next Steps

• Continue to execute on strategy to accelerate the individual market.
• Leverage consumer products, disciplined pricing, and technology platform for long-term profitable growth.
• Host a conference call on August 6, 2026, to discuss financial results.

Key Dates

Recommendation

The filing demonstrates a significant turnaround in financial performance, with record profitability, substantial improvements in key operating metrics (MLR, SG&A), and a strong beat on earnings expectations. The raised full-year guidance further solidifies this positive trajectory. The company's strategic focus on the individual market, coupled with its technological capabilities, positions it for sustained profitable growth, making it an attractive investment.

Keywords

health insurance, medical loss ratio, SG&A expense ratio, Adjusted EBITDA, earnings from operations, membership growth, healthcare technology, financial results